- Q4 2024 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2024₹1032.3 (+0.28%)Earnings
- Q3 2024 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2024₹887.1 (+0.26%)Earnings
- Q2 2024 Natco Pharma Ltd Earnings Call TranscriptNov 15, 2023₹758.65 (-4.48%)Earnings
- Natco Pharma Ltd Annual Shareholders Meeting TranscriptSep 29, 2023
- Q1 2024 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2023₹876.05 (-1.97%)Earnings
- Q4 2023 Natco Pharma Ltd Earnings Call TranscriptMay 30, 2023₹619.5 (-2.15%)Earnings
- Q3 2023 Natco Pharma Ltd Earnings Call TranscriptFeb 10, 2023₹524.85 (-0.88%)Earnings
- Q2 2023 Natco Pharma Ltd Earnings Call TranscriptNov 11, 2022₹584 (-0.72%)Earnings
- Q1 2023 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2022₹672.85 (-10.35%)Earnings
- Q4 2022 Natco Pharma Ltd Earnings Call TranscriptMay 31, 2022₹690.95 (+3.72%)Earnings
- Q3 2022 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2022₹895.35 (-2.40%)Earnings
- Q2 2022 Natco Pharma Ltd Earnings Call TranscriptNov 12, 2021₹828.7 (+0.55%)Earnings
- Q1 2022 Natco Pharma Ltd Earnings Call TranscriptAug 12, 2021₹1041.45 (+3.06%)Earnings
- Q4 2021 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2021₹1095.8 (+1.25%)Earnings
- Q3 2021 Natco Pharma Ltd Earnings Call TranscriptFeb 12, 2021₹854 (-3.64%)Earnings
- Q2 2021 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2020₹900.9 (-0.63%)Earnings
- Q1 2021 Natco Pharma Ltd Earnings Call TranscriptAug 13, 2020₹813.4 (-4.17%)Earnings
- Q4 2020 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2020₹620.05 (+0.99%)Earnings
- Q3 2020 Natco Pharma Ltd Earnings Call TranscriptFeb 13, 2020₹673.95 (-4.91%)Earnings
- Q2 2020 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2019₹560.15 (-3.19%)Earnings
- Q1 2020 Natco Pharma Ltd Earnings Call TranscriptAug 09, 2019₹551.45 (-0.27%)Earnings
- Q4 2019 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2019₹529.9 (+0.94%)Earnings
Q4 2022 Natco Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the NATCO Pharma Q4 FY '22 Conference Call, hosted by Edelweiss Securities Limited. (Operator Instructions) I now hand the conference over to Mr. Kunal Randeria from Edelweiss Securities Limited. Thank you, and over to you, sir.
Thank you, Diksha, and good morning, everyone. On behalf of Edelweiss Securities, I welcome you all for NATCO Pharma's Q4 FY '22 Earnings Call. With us, we have NATCO Pharma's senior management, represented by Mr. Rajeev Nannapaneni, Director and Chief Executive Officer; and Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences. So over to you, Rajesh for opening remarks.
Right. Thank you, Kunal. Good morning, and welcome, everyone, to NATCO's conference call, discussing our earnings results for the fourth quarter of FY '22 and for the full year, which ended March 31, 2022.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)